Onderzoeker
Ewout Landeloos
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Celdood, Kankerbiologie
- Disciplines (KU Leuven):Oncologie
Affiliaties
- Departement Oncologie (Departement)
Lid
Vanaf22 aug 2022 → Heden - Laboratorium voor Moleculaire Kankerbiologie (VIB-KU Leuven) (Afdeling)
Lid
Vanaf6 aug 2018 → 5 aug 2022 - Marine Lab (Onderzoeksgroep)
Lid
Vanaf6 aug 2018 → 5 aug 2022
Publicaties
1 - 10 van 10
- A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma(2024)
Auteurs: Dennis Pedri, Ewout Landeloos, Yannick Van Herck, Katy Vandereyken, Thierry Voet, Wim Annaert, Diether Lambrechts, Veerle Boecxstaens, Joost van den Oord, Francesca Bosisio, et al.
- SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response(2022)
Auteurs: Ewout Landeloos, Yannick Van Herck, Oliver Bechter, Chris Marine
- A cellular hierarchy in melanoma uncouples growth and metastasis (vol 610, pg 190, 2022)(2022)
Auteurs: Panagiotis Karras, Joanna Poźniak, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Michael Dewaele, Yichao Hua, Gabriele Bergers, Francesca Bosisio, Joost van den Oord, et al.
Pagina's: E4 - E4 - A cellular hierarchy in melanoma uncouples growth and metastasis(2022)
Auteurs: Panagiotis Karras, Ada Nowosad, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Dennis Pedri, Michael Dewaele, Yichao Hua, Gabriele Bergers, Francesca Bosisio, et al.
Pagina's: 190 - + - Epithelial-to-mesenchymal-like transition events in melanoma(2022)
Auteurs: Dennis Pedri, Panagiotis Karras, Ewout Landeloos, Chris Marine
Pagina's: 1352 - 1368 - Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer(2022)
Auteurs: Ward Celus, Silvia Rivis, Ewout Landeloos, Yannick Van Herck, Abhishek Garg, Chris Marine, Mario di Matteo, Oliver Bechter, Max Mazzone
Pagina's: 126 - 141 - itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)(2021)
Auteurs: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Bert Vandenberk, Lorenz Van der Linden, et al.
- Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial(2021)
Auteurs: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Laure-Anne Teuwen, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Vincent Geldhof, et al.
- Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin (vol 22, 126, 2021)(2021)
Auteurs: Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, Ann Belmans, Geert Verbeke, Peter Verhamme, Robin Vos, Wim Janssens
Pagina's: 0 - 0 - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial(2021)
Auteurs: Iwein Gyselinck, Ewout Landeloos, Ann Belmans, Geert Verbeke, Peter Verhamme, Robin Vos, Wim Janssens